Mideast Stocks: Factors to watch on February 26
Here are some factors that may affect Middle East stock markets on Tuesday
Reuters News - 26 Feb 2019
Mouwasat Medical Services Company (4002.SE)
Also known as: Mouwasat
129.40 SAR -0.20-0.15%
Mouwasat Stock Price & Performance
Recommendation
-
Div Yield
-
P/E (Last 12 Month)
25.07
Upside
-
Target Price (Mean)
-
Open
130.20 SAR
Previous Close
129.40 SAR
Turnover
9.74M SAR
EPS
5.153 SAR
Volume
75,577
Transactions
657
Market Cap
12.94B SAR
IPO Date
02-Sep-2009
Analyst Estimates
| EPS | Revenue | |
|---|---|---|
| Mean Estimate |  | |
| Smart Estimate | | |
| Predicted Surprise | | |
| Mean Chg % | | |
Starmine Models
StarMine provides a suite of proprietary alpha-generating analytics and models spanning sectors, regions, and markets.
| Bullish | |
|---|---|
| Value Momentum | |
| Intrinsic Valuation | |
| Relative Valuation | |
| Credit Risk - Smart Ratios | |
| Credit Risk- Text Mining | |
| Bearish | |
|---|---|
| Price Momentum | |
About Mouwasat Medical Services Company
Business Summary
Ownership and operation of hospitals, clinics, medical centers and pharmacies.
Country of Incorporation
Ownership Type
Established In
1997
Primary Sector
Stock Listing
| ID | Stock Type | Currency | Exchange | Symbol |
|---|---|---|---|---|
| 4002.SSE | Ordinary | SAR | Saudi SE | 4002 |
Contact details
Primary address
Building: Mouwasat Medical Services Company, Block 71Street: King Fahad Road
Area: Uhod District
P.O. Box: 282
Country: Saudi Arabia
City: Dammam
City Suffix: 31411
CONTACT
- Tel: +966 13-820-0000
- Tel: +966 13-820-0016
- Fax: +966 13-820-3436
- Fax: +966 13-820-0014
- Email: info@mouwasat.com
- www.mouwasat.com
Related links
www.badanaclinic.comRegion
Eastern ProvinceOwnership
Ownership
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Holding Concentrations
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Financials
Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing
Executives
Mr Naser Sultan Fahad Al Subaie
Chief Executive Officer
Mr Mohammed Bin Suleiman Mohammed Al Saleem
Managing Director
Mr Khalid Bin Suleiman Mohammed Al Saleem
Deputy Managing Director
Board Members
Mr Mohammed Sultan Hamad Al Subaie
Chairman
Mr Naser Sultan Fahad Al Subaie
Vice Chairman
Mr Mohammed Bin Suleiman Mohammed Al Saleem
Director
Company information provided by Refinitiv
Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
Zawya Coverage
Markets are recovering. Is it too late to buy?
Thursday Outlook: Gold rise to an over one-week high; oil prices drop
End of gold bull run? Further losses expected as vaccine hopes rise
Six key credit themes for global asset management sector in 2021
Wednesday Outlook: Dollar hovers near 2-1/2 year low; gold prices dip
Thursday Outlook: Gold rise to an over one-week high; oil prices drop
Hopes that the pandemic will finally be brought to its knees sparked a risk-on rally in the markets
Stock Market Data
Powered By Knowledge Direct